Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2004-04-29 | Michael D. Casey, 58, became a director of the Company in January 2004, filling a newly created vacancy on the Board of Directors. Mr. Casey, who currently works as a consultant in the biopharmaceutical field, was the Chairman, President, and Chief Executive Officer and a Director of Matrix Pharmaceutical, Inc., a publicly traded cancer therapy company until it was acquired by Chiron Corporation in March 2002. |
| 2005-03-07 | Michael D. Casey, 59, became a director of the Company in January 2004, filling a newly created vacancy on the Board of Directors. Mr. Casey, who currently works as a consultant in the biopharmaceutical field, was the Chairman, President, and Chief Executive Officer and a Director of Matrix Pharmaceutical, Inc., a publicly traded cancer therapy company until it was acquired by Chiron Corporation in March 2002. |
| 2006-04-14 | Mr. Casey, who currently works as a consultant in the biopharmaceutical field, was the Chairman, President, and Chief Executive Officer and a Director of Matrix Pharmaceutical, Inc. |
| 2007-04-09 | Michael D. Casey, 61, became a director of the Company in January 2004, filling a newly created vacancy on the Board of Directors. Mr. Casey informed the OrthoLogic Board of Directors on March 28, 2007, that he does not intend to seek re-election to the Board at the Annual Meeting of Stockholders on May 10, 2007 due to personal and family commitments. |
| Filing Date | Source Excerpt |
|---|---|
| 2010-05-04 | Mr. Casey's experience in leadership positions in public companies in the biopharmaceutical industry qualifies him for service as a member of the Board of Directors. Since 2002, Mr. Casey has served as a director of several public biopharmaceutical companies. |
Data sourced from SEC filings. Last updated: 2025-08-30